Glutamate Receptors in Neuroinflammatory Demyelinating Disease

Glutamate Receptors in Neuroinflammatory Demyelinating Disease

<p>Multiple sclerosis (MS) is a chronic demyelinating disease of the human central nervous system (CNS). The condition predominantly affects young adults and is characterised by immunological and inflammatory changes in the periphery and CNS that contribute to neurovascular disruption, haemopo...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Hindawi Limited 2006-01-01
Series:	Mediators of Inflammation
Online Access:	http://www.hindawi.com/GetArticle.aspx?doi=10.1155/MI/2006/93684

Similar Items

Glutamate Receptors in Neuroinflammatory Demyelinating Disease
by: Christopher Bolton, et al.
Published: (2006-01-01)

Nerve Demyelination Increases Metabotropic Glutamate Receptor Subtype 5 Expression in Peripheral Painful Mononeuropathy
by: Miau-Hwa Ko, et al.
Published: (2015-03-01)

EMR-integrated minimal core dataset for routine health care and multiple research settings: A case study for neuroinflammatory demyelinating diseases.
by: Sophia von Martial, et al.
Published: (2019-01-01)

Inflammasomes in neuroinflammatory and neurodegenerative diseases
by: Sofie Voet, et al.
Published: (2019-06-01)

Glia Crosstalk in Neuroinflammatory Diseases
by: Ada Bernaus, et al.
Published: (2020-07-01)

The role of hypoxia in neuroinflammatory disease
by: Desai, R. A.
Published: (2013)

Demyelinating disease
by: Xiao-ling YAN
Published: (2013-06-01)

Demyelinating disease
by: YAN Xiao-ling
Published: (2013-06-01)

In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease
by: Anna Vuorimaa, et al.
Published: (2017-01-01)

Role of Scavenger Receptors in Glia-Mediated Neuroinflammatory Response Associated with Alzheimer’s Disease
by: Francisca Cornejo, et al.
Published: (2013-01-01)

Kynurenine pathway metabolism and neuroinflammatory disease
by: Nady Braidy, et al.
Published: (2017-01-01)

Neuroinflammatory paradigms in lysosomal storage diseases
by: Megan Elizabeth Bosch, et al.
Published: (2015-10-01)

Role of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases
by: Isabel Vieira de Assis Lima, et al.
Published: (2012-01-01)

The neuroinflammatory role of Schwann cells in disease
by: Elke Ydens, et al.
Published: (2013-07-01)

Axonal protection in models of neuroinflammatory disease
by: Bechtold, David Alexander
Published: (2005)

Studies in demyelinating disease
by: Lumsden, C. E.
Published: (1948)

Critical Roles of Lysophospholipid Receptors in Activation of Neuroglia and Their Neuroinflammatory Responses
by: Bhakta Prasad Gaire, et al.
Published: (2021-07-01)

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
by: Vo Van Giau, et al.
Published: (2018-11-01)

Mitochondrial Dynamics in Cancer and Neurodegenerative and Neuroinflammatory Diseases
by: Mauro Corrado, et al.
Published: (2012-01-01)

Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases
by: Marcella Reale, et al.
Published: (2021-04-01)

Roles of Glutamate Receptors in Parkinson’s Disease
by: Zhu Zhang, et al.
Published: (2019-09-01)

Microglia P2Y6 receptor is related to Parkinson’s disease through neuroinflammatory process
by: Xiaodong Yang, et al.
Published: (2017-02-01)

Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro
by: H Wilms, et al.
Published: (2003-12-01)

P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown
by: Susanna Amadio, et al.
Published: (2014-01-01)

Neuroradiological evaluation of demyelinating disease
by: Jan-Mendelt Tillema, et al.
Published: (2013-07-01)

Macrophages and Autoantibodies in Demyelinating Diseases
by: Haruki Koike, et al.
Published: (2021-04-01)

Azadirachta indica A. Juss Ameliorates Mouse Hepatitis Virus-Induced Neuroinflammatory Demyelination by Modulating Cell-to-Cell Fusion in an Experimental Animal Model of Multiple Sclerosis
by: Lucky Sarkar, et al.
Published: (2020-05-01)

Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases
by: Seth N. Levin, et al.
Published: (2021-04-01)

Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases
by: Johannes Dorst, et al.
Published: (2020-09-01)

The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases
by: Annika Sommer, et al.
Published: (2017-10-01)

Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases
by: Sarah Hirschberg, et al.
Published: (2019-06-01)

Marine-derived protein kinase inhibitors for neuroinflammatory diseases
by: Chong Ning, et al.
Published: (2018-04-01)

Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
by: Catarina M. Abreu, et al.
Published: (2018-05-01)

Homeostasis of myeloid cells in the CNS and their roles in neuroinflammatory disease
by: Ajami, Bahareh
Published: (2011)

Regenerative Effects of Heme Oxygenase Metabolites on Neuroinflammatory Diseases
by: Huiju Lee, et al.
Published: (2018-12-01)

Homeostasis of myeloid cells in the CNS and their roles in neuroinflammatory disease
by: Ajami, Bahareh
Published: (2011)

Homeostasis of myeloid cells in the CNS and their roles in neuroinflammatory disease
by: Ajami, Bahareh
Published: (2011)

Identifying the origin and mechanisms of pathological angiogenesis in neuroinflammatory diseases
by: Shahriar, Sanjid
Published: (2022)

Temporal Changes in In Vivo Glutamate Signal During Demyelination and Remyelination in the Corpus Callosum: A Glutamate-Weighted Chemical Exchange Saturation Transfer Imaging Study
by: Do-Wan Lee, et al.
Published: (2020-12-01)

Microglia P2X4 receptors as pharmacological targets for demyelinating diseases
by: Francesco Di Virgilio, et al.
Published: (2018-08-01)